Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

More ACS news: SmithKline Beecham continues to research CXCR2 antagonists

March 29, 1999

New candidate for treatment of atopic dermatitis synthesized at Nissan Chemical

March 29, 1999

ACS highlights: potent and selective small-molecule CXCR2 antagonists in early development at SB

March 26, 1999

Cellegy reacquires Glylorin rights from Glaxo Wellcome

March 25, 1999

Connetics launches Luxiq at Dermatology Conference

March 23, 1999

Fujisawa decides not to enter Solarase licensing agreement with Hyal

March 16, 1999

CysLT1 antagonists show potential as Rx for chronic urticaria

March 15, 1999

DDE-131, a potential treatment for mast cell-mediated hypersensitivity

March 11, 1999

ICN launches Senetek's antiaging product

March 10, 1999

rsIL-4R as a potential treatment for atopic eczema

March 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...